Name |
CD25 (Interleukin 2 Receptor alpha) |
Alternative name/Profile |
IL2, IL-2, Hemophagocytic Lymphohistiocytosis (HLH) |
Department |
Immunology |
Investigation |
ELISA (R&D Systems, Quantikine ELISA, Human CD25/IL-2 Rα Immunoassay) |
Specimen type |
Clotted blood |
Sample type |
Serum |
Sample container & volume |
5ml Red. |
Frequency of analysis |
Batch basis |
Turnaround time |
21 Days |
Availability |
|
Notes |
Useful for:
- Evaluating patients with Hemophagocytic Lymphohistiocytosis (HLH).
Clinical Information:
- Hemophagocytic Lymphohistiocytosis (HLH) is a severe inflammatory disorder in which there is abnormal cytotoxic T and Natural Killer cell function and excessive cytokine production. This results in continued activation of the immune system and impaired pathogen clearance.
- Hemophagocytic Lymphohistiocytosis (HLH) can be characterised by using 6 clinical parameters; fever, splenomegaly, cytopenias, hyperferritinemia, hypertriglyceridemia/hypofibrinogenemia, and hemophagocytosis, as well as 3 laboratory tests (genetic testing, NK cell function, and serum soluble interleukin-2).
- CD25 (Interleukin 2 Receptor alpha) levels are usually elevated in Hemophagocytic Lymphohistiocytosis (HLH).
Please Note:
- Samples for CD25 (Interleukin 2 Receptor alpha) must be received in the laboratory as soon as possible post collection.
|
Related links |
|
Reference range |
101.8 - 2509.4 pg/ml
This reference range was established inhouse using the maximum and minimum values +/- 2 SD from 30 healthy adult controls in the Immunology Department, St. James's Hospital. |
Last updated |
Wed, 09 Mar 2022 09:26:31 GMT |